1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRein in Sarcoma Research Grants is sponsored by Rein in Sarcoma. Supports sarcoma research projects, primarily at the University of Minnesota and Mayo Clinic.
Get alerted about grants like this
Get emailed when new opportunities from “Rein in Sarcoma” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Rein in Sarcoma Awards $50,000 Research Grant - Rein in Sarcoma The Next 25 Years Begin Now We welcome you to join us as we build our bold vision for a world without sarcoma cancer. Rein in Sarcoma Awards $50,000 Research Grant Rein in Sarcoma Awards $50,000 Research Grant Rein in Sarcoma’s Board approved a $50,000 research grant to the University of Minnesota.
The University solicited requests for funding proposals from their researchers, blindly ranking them according to national standards, and then recommended the proposal submitted by Erin Dickerson, PhD.
Project Title: Targeting the Cell Cycle and Autophagy Reciprocal Communication Pathways in Sarcomas Principal Investigator: Erin Dickerson, PhD Associate Professor, Veterinary Clinical Sciences Institution: University of Minnesota That autophagy and cell cycle signaling pathways regulate specific subtypes in hemangiosarcoma, and combinatorial approaches targeting these pathways will enhance antitumor responses.
Our goal is to identify pathways that drive angiosarcoma progression and to develop new treatment options to improve patient outcomes. By analyzing tumors from dogs enrolled in an ongoing clinical trial, we have identified targetable subtypes that have allowed us to design a combinatorial treatment strategy that may translate to human patients diagnosed with angiosarcoma.
Data from this project will be used to support grant proposals to rigorously characterize the identified subtypes and to refine the development of our approach. The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage {vendor_count} vendors The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors
According to the current listing, eligibility includes: Researchers at University of Minnesota and Mayo Clinic. Confirm the full requirements in the official notice before applying.
Rein in Sarcoma Research Grants is funded by Rein in Sarcoma. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Minnesota. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.